Patent 10478402 was granted and assigned to Nanexa on November, 2019 by the United States Patent and Trademark Office.
A nanoparticle having a solid core comprising a biologically active substance, said core being enclosed by an inorganic coating, a method for preparing the nanoparticle, and the use of the nanoparticle in therapy. A kit comprising the nanoparticle and a pharmaceutical composition comprising the nanoparticle.